- A - NCE New Chemical Entity
- A - NCE New Salt or Ester of Existing Active Ingredient
- A - NCE Similar Biological Medicinal Product
- B - New Combination
- C - Extension of Indication
- D - New Generic Medicine
- F - Major Variation - New Strength
- F - Major Variation - New Dosage Form
- F - Major Variation - New Route of Administration
- F - Major Variation - Change in Patient Group
- F - Major Variation - Change of Dosage
- J - PI Change requiring evaluation
- G - Minor Variation, New Register Entry - Change of Formulation
- G - Minor Variation, New Register Entry - New Container Type
- H - Minor Variation, Not Resulting in a New Register Entry
- E - Additional Tradename
- Change of Tradename
- K - PI Change without Data
- Rolling Review
- 9D(1) - Correction of Register Entry
- 9D(2) - Safety Related Request
- 9D(3) - Change to PI (not J)
- OTC - N1
- OTC - N2
- OTC - N3
- OTC - N4
- OTC - N5
- OTC - C1
- OTC - C2
- OTC - C3
- OTC - C4
- OTC - New Active Ingredient
- Ingredient - New
- Ingredient - Variation
- Complementary Medicine - New
- Complementary Medicine - Variation
- Biologicals - Class 1
- Biologicals - Class 2
- Biologicals - Class 3
- Biologicals - Class 4
- Biologicals - Variation
- Medical Devices
- ASMF / DMF
- Plasma Master File (PMF)
- Tissue Master File (TMF)
- Biological Master File (BMF)
- Pharmacovigilance
- Periodic Safety Update Report
- Risk Management Plan
- Change of Sponsor
- Supplementary information
- Baseline
- Clinical Trial Application
- Pre-Submission Meeting Documentation
- Pre-Submission Planning Form
- Withdrawal
- Undefined Regulatory Activity*
- This replaces 'J - PI Change with Data'
- This replaces 'G - Minor Variation, New Register Entry - Change of Tradename'
- This replaces 'Excipient - New'
- This replaces 'Excipient - Variation'